𝔖 Bobbio Scriptorium
✦   LIBER   ✦

TTP disease course is independent of myeloma treatment and response

✍ Scribed by Craig C. Hofmeister; Ming Jin; Spero R. Cataland; Don M. Benson; Haifeng M. Wu


Book ID
101438585
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
346 KB
Volume
85
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Multiple myeloma: An immunoclinical stud
✍ P. W. Thavasu; R. K. Ganjoo; S. A. Maidment; S. B. Love; A. H. Williams; J. S. M πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 826 KB

Plasma cytokines and immune markers were assessed during the clinical management of 42 patients with multiple myeloma, MM. Of the patients 22/42 (all with progressive disease) were studied from the time of diagnosis, through various treatment regimes, to remission, progression or death. 5/42 patient

Sequential evaluation of serum hepcidin
✍ Eirini Katodritou; Tomas Ganz; Evangelos Terpos; Evgenia Verrou; Gordana Olbina; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 802 KB

Hepcidin is a liver-derived hormone with a central role in iron regulation and in anemia of inflammation. Its correlations with disease variables, anemia response (AR), and responses to treatment have not been investigated in multiple myeloma (MM). A cohort of anemic MM patients undergoing treatment

Rapid response to paroxetine is associat
✍ Reiji Yoshimura; Wakako Umene-Nakano; Akihito Suzuki; Nobuhisa Ueda; Kyoko Miyam πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 1 views

## Abstract In the present study, we investigated the relationship between the serotonin transporter gene linked polymorphic regions (5‐HTTLPR) or plasma paroxetine levels and clinical response to paroxetine in depressed patients. Sixty patients who met the DSM‐IV criteria for major depressive diso